跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHARMACY ACTION MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension spray bottle - TGA Drug Approval Details
Approvals
/
TGA
/
PHARMACY ACTION MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension spray bottle
Approved
STANDARD
PHARMACY ACTION MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension spray bottle
Generic Health Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
39fb3a2e7cf312a1
Company
Generic Health Pty Ltd
Type
Standard
Approval Details
Approval Id
39fb3a2e7cf312a1
Product Name
PHARMACY ACTION MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension spray bottle
Artg Id
343458
Artg Name
PHARMACY ACTION MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension spray bottle
Sponsor
Generic Health Pty Ltd
Company Detail Path
/organization/generic-health-pty-ltd
Artg Date
2020-09-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
39fb3a2e7cf312a1
Type
Standard
Back to TGA Approvals
